Biotoxtech Co., Ltd. (KOSDAQ:086040)

Market Cap	37.42B -12.7%
Revenue (ttm)	47.64B +9.3%
Net Income	769.13M
EPS	49.48
Shares Out	15.72M
PE Ratio	48.10
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,096
Open	2,355.00
Previous Close	2,335.00
Day's Range	2,305.00 - 2,395.00
52-Week Range	1,896.00 - 4,115.00
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Biotoxtech

Biotoxtech Co., Ltd. engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea. It is involved in testing and substance screening, clinical pathology and histopathology work, and consulting and government affairs related to non-clinical trials, as well as new drug development. The company’s safety evaluation research field includes general toxicity test, carcinogenicity studies, local toxicity studies, reproductive and de...

• Industry: Medical Laboratories
• Founded: 2000
• Employees: 188
• Stock Exchange: KOSDAQ
• Ticker Symbol: 086040

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 24, 2026

Data Sources Report a data error